Volitionrx limited announces pricing of $7.525 million underwritten public offering of common stock

Henderson, nev. , feb. 17, 2023 /prnewswire/ -- volitionrx limited (nyse american: vnrx) ("volition" or the "company"), a multi-national epigenetics company, announced today the pricing of an underwritten public offering of 4,300,000 shares of its common stock at a public offering price of $1.75 per share.
VNRX Ratings Summary
VNRX Quant Ranking